BREAKAWAY Trademark

Trademark Overview

On Monday, May 5, 2025, a trademark application was filed for BREAKAWAY with the United States Patent and Trademark Office. The USPTO has given the BREAKAWAY trademark a serial number of 99169936. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, December 18, 2025. This trademark is owned by Orlance, Inc.. The BREAKAWAY trademark is filed in the Computer & Software Services & Scientific Services, Personal and Legal & Social Services categories with the following description:

Regulatory compliance consulting services in the fields of pharmaceuticals, healthcare, medical services, and life sciences; regulatory compliance with pharmaceutical, medical, healthcare, and life sciences laws and regulations; regulatory compliance consulting services, namely, providing support for the development, validation, and production of drugs, biologics, and medical devices

Scientific research services, namely, conducting clinical research and clinical trials; research and development services in the field of pharmaceuticals, medical treatments, and healthcare technologies; consulting services in the field of scientific research for the healthcare and pharmaceutical industry; providing technological and scientific information in the field of healthcare and pharmaceutical research; medical research services, namely, analyzing healthcare and pharmaceutical data to improve medical practices, patient care, and drug efficacy
breakaway

General Information

Serial Number99169936
Word MarkBREAKAWAY
Filing DateMonday, May 5, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, December 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesRegulatory compliance consulting services in the fields of pharmaceuticals, healthcare, medical services, and life sciences; regulatory compliance with pharmaceutical, medical, healthcare, and life sciences laws and regulations; regulatory compliance consulting services, namely, providing support for the development, validation, and production of drugs, biologics, and medical devices
Goods and ServicesScientific research services, namely, conducting clinical research and clinical trials; research and development services in the field of pharmaceuticals, medical treatments, and healthcare technologies; consulting services in the field of scientific research for the healthcare and pharmaceutical industry; providing technological and scientific information in the field of healthcare and pharmaceutical research; medical research services, namely, analyzing healthcare and pharmaceutical data to improve medical practices, patient care, and drug efficacy
Pseudo MarkBREAK AWAY

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 5, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 5, 2025
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOrlance, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 98104

Trademark Events

Event DateEvent Description
Monday, May 5, 2025NEW APPLICATION ENTERED
Monday, May 5, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 5, 2025APPLICATION FILING RECEIPT MAILED
Monday, September 22, 2025ASSIGNED TO EXAMINER
Wednesday, September 24, 2025NON-FINAL ACTION WRITTEN
Wednesday, September 24, 2025NON-FINAL ACTION E-MAILED
Wednesday, September 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 18, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 18, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 18, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

breakaway services medical research healthcare pharmaceutical scientific regulatory field compliance consulting